| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.00058 | 1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.00049 | 1 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.00042 | 1 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.0004 | 1 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.0005 | 1 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00037 | 1 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.00027 | 1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.0003 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.00025 | 1 |